An in-depth look to DAEWON PHARMACEUTICAL operating, investing, and financing activities

003220 free cash flow for Q2 24 is -8.31 B KRW. For 2023, 003220 free cash flow was 35.38 B KRW and operating cash flow was 48.99 B KRW.